Similar articles for PMID: 17003144

Year	Number of Results
1895	1
1899	1
1911	1
1930	1
1932	1
1936	1
1951	1
1964	6
1970	1
1993	3
1994	5
1995	2
1996	7
1997	3
1998	6
1999	9
2000	21
2001	14
2002	6
2003	13
2004	10
2005	17
2006	23
2007	18
2008	24
2009	17
2010	6
2011	9
2012	3
2013	11
2014	5
2015	4
2016	7
2017	5
2018	7
2019	1
2020	2
2021	2
2022	0

1

US men discussing prostate-specific antigen tests with a physician.

McFall SL. McFall SL. Ann Fam Med. 2006 Sep-Oct;4(5):433-6. doi: 10.1370/afm.576. Ann Fam Med. 2006. PMID: 17003144 Free PMC article.

2

Physician-patient discussions with african american men about prostate cancer screening.

Ross LE, Powe BD, Taylor YJ, Howard DL. Ross LE, et al. Am J Mens Health. 2008 Jun;2(2):156-64. doi: 10.1177/1557988307309323. Epub 2007 Dec 5. Am J Mens Health. 2008. PMID: 19477779 Free article.

3

Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.

Han PK, Coates RJ, Uhler RJ, Breen N. Han PK, et al. Am J Prev Med. 2006 May;30(5):394-404. doi: 10.1016/j.amepre.2005.12.006. Epub 2006 Mar 23. Am J Prev Med. 2006. PMID: 16627127

4

Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?

O'Dell KJ, Volk RJ, Cass AR, Spann SJ. O'Dell KJ, et al. J Fam Pract. 1999 Sep;48(9):682-8. J Fam Pract. 1999. PMID: 10498074

5

Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).

Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ. Hoffman RM, et al. Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262. Arch Intern Med. 2009. PMID: 19786681

6

Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.

Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A, Elwyn G, Cargill A, Austoker J. Watson E, et al. Patient Educ Couns. 2006 Nov;63(3):367-79. doi: 10.1016/j.pec.2006.05.005. Epub 2006 Jul 27. Patient Educ Couns. 2006. PMID: 16875796 Clinical Trial.

7

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.

Ross LE, Berkowitz Z, Ekwueme DU. Ross LE, et al. Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44. doi: 10.1158/1055-9965.EPI-07-2709. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18349281

8

The impact of informed consent on patient interest in prostate-specific antigen screening.

Wolf AM, Nasser JF, Wolf AM, Schorling JB. Wolf AM, et al. Arch Intern Med. 1996 Jun 24;156(12):1333-6. Arch Intern Med. 1996. PMID: 8651843 Clinical Trial.

9

A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.

Spencer BA, Babey SH, Etzioni DA, Ponce NA, Brown ER, Yu H, Chawla N, Litwin MS. Spencer BA, et al. Cancer. 2006 Feb 15;106(4):765-74. doi: 10.1002/cncr.21673. Cancer. 2006. PMID: 16419068 Free article.

10

Informed consent for PSA screening: does it happen?

Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J. Federman DG, et al. Eff Clin Pract. 1999 Jul-Aug;2(4):152-7. Eff Clin Pract. 1999. PMID: 10539539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed